| ₹ crore | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Revenue | 169 | 135 | +24.7% |
| EBITDA | −26.3 | −19.6 | — |
| EBITDA margin | −15.6% | −14.5% | −1.1 pts |
| Profit before tax | −28.4 | −5.2 | — |
| Net profit | 41.6 | −2.8 | — |
| EPS | ₹0.22 | −₹0.02 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast close | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 210 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.1 | 1.1 | 5.7 | 13.8 | 9.6 | ||
| −0.5 | −0.5 | 1.4 | 1.7 | 2.3 | ||
| 105 | 105 | 76.2 | 34.5 | 30.4 | ||
| 314 | — | — | — | — | ||
| 499 | 499 | 480 | 446 | 476 | ||
| — | +4.0% | +7.7% | −6.4% | — | ||
| −48.3 | −48.3 | −21.6 | 4.3 | 11.8 | ||
| −9.7% | −9.7% | −4.5% | 1.0% | 2.5% | ||
| −54.3 | −54.3 | −28.3 | 0.7 | 8.8 | ||
| 18.4 | 18.4 | −10.9 | 13.5 | −15.5 | ||
| 3.7% | 3.7% | −2.3% | 3.0% | −3.3% | ||
| ₹0.10 | ₹0.10 | −₹0.06 | ₹0.08 | −₹0.08 | ||
| — | +268.6% | −177.8% | +191.7% | — | ||
| 310 | 310 | −222 | −41.7 | −110 | ||
| −1.6 | −1.6 | 0.0 | −16.0 | −17.8 | ||
| 308 | 308 | −222 | −57.7 | −128 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 210.2 | |
| - Cash, Equiv & ST Investments | 9.6 | 13.8 | 5.7 | 1.1 | 1.1 | |
| + Minority Interest | 2.3 | 1.7 | 1.4 | -0.5 | -0.5 | |
| + Total Debt | 30.4 | 34.5 | 76.2 | 105.1 | 105.1 | |
| Enterprise Value | — | — | — | — | 313.7 | |
| Revenue | 476.0 | 445.7 | 480.0 | 499.4 | 499.4 | |
| Growth %, YoY | — | -6.4 | +7.7 | +4.0 | — | |
| EBITDA | 11.8 | 4.3 | -21.6 | -48.3 | -48.3 | |
| Margin % | 2.47 | 0.97 | -4.50 | -9.68 | -9.68 | |
| EBIT | 8.8 | 0.7 | -28.3 | -54.3 | -54.3 | |
| Net Income | -15.5 | 13.5 | -10.9 | 18.4 | 18.4 | |
| Margin % | -3.26 | 3.02 | -2.27 | 3.68 | 3.68 | |
| EPS, Adj (current shares) | -0.08 | 0.08 | -0.06 | 0.10 | 0.10 | |
| Growth %, YoY | — | +191.7 | -177.8 | +268.6 | — | |
| Cash from Operations | -110.2 | -41.7 | -222.2 | 309.6 | 309.6 | |
| Capital Expenditures | -17.8 | -16.0 | -0.0 | -1.6 | -1.6 | |
| Free Cash Flow | -128.0 | -57.7 | -222.2 | 308.1 | 308.1 | |
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹18.4 crore on revenue of ₹499 crore. Its debt-to-equity ratio was 0.19 on 31 March 2026. Promoters held 14.20% of the shares on 30 September 2026.
No. Vikas Lifecare had borrowings of ₹105 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.19. Its cash and current investments were ₹1.1 crore, so its net debt was ₹104 crore.
Vikas Lifecare's debt-to-equity ratio was 0.19 on 31 March 2026: borrowings of ₹105 crore against total equity of ₹551 crore. A year earlier, on 31 March 2025, it was 0.14.
Promoters held 14.20% of Vikas Lifecare on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Vikas Lifecare's net worth — shareholders' equity in its consolidated balance sheet — was ₹551 crore on 31 March 2026, up 3.7% from ₹532 crore a year earlier.
Vikas Lifecare's book value per share was ₹2.97 on 31 March 2026: shareholders' equity of ₹551 crore divided by the 185.98 crore shares in issue, up 3.7% from ₹2.86 a year earlier.
Vikas Lifecare's basic earnings per share (EPS) were ₹0.10 in FY26.
In FY26, Vikas Lifecare's return on equity (ROE) was 3.4% and its return on capital employed (ROCE) was −9.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −2.2% and ROCE −5.3%.
On 30 September 2026, Vikas Lifecare's shares were held by promoters 14.20%, foreign portfolio investors (FII/FPI) 0.26%, domestic institutions (DII) 0.00% and retail and other non-institutional investors 85.54%. Over the year, FII holding was down 0.04 percentage points from 0.30% and DII holding was unchanged.
Vikas Lifecare's latest results are for Q4 FY26 (January–March 2026), filed on 22 April 2026: consolidated net profit ₹41.6 crore, against a loss of ₹2.8 crore in Q4 FY25; revenue from operations ₹169 crore, up 24.7% year on year.
In FY26, Vikas Lifecare generated ₹310 crore of cash from operations and spent ₹1.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹308 crore. In FY25 it was −₹222 crore.
In FY26 (April 2025–March 2026), Vikas Lifecare's consolidated net profit was ₹18.4 crore, against a loss of ₹10.9 crore in FY25, on revenue from operations of ₹499 crore (up 4.0%).
In FY26, Vikas Lifecare earned net profit of ₹18.4 crore on revenue of ₹499 crore, against ₹9.5 crore on ₹1,708 crore for Sakuma Exports. Vikas Lifecare's operating margin was −10.9% (Sakuma Exports 0.3%) and its return on equity 3.4% (Sakuma Exports 1.3%).
On FY26 consolidated figures, against Sakuma Exports, Integra Essentia and Kothari Products: Vikas Lifecare's operating margin of −10.9% is the lowest of the four (Sakuma Exports 0.3%, Integra Essentia −0.6%, Kothari Products −5.0%; peer average −1.8%); its return on equity of 3.4% is the highest of the four (Sakuma Exports 1.3%, Integra Essentia 0.2%, Kothari Products 2.7%; peer average 1.4%); its revenue growth over three years of 1.6% a year is the second highest of the four (Sakuma Exports −18.7% a year, Integra Essentia 25.2% a year, Kothari Products −10.0% a year; peer average −1.2% a year).
From Vikas Lifecare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.